Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Genevieve A. Laforet"'
Validation of an ambient measurement system (AMS) for physical activities in a paediatric population
Autor:
Timothy W. Chevalier, Zebadiah M Kimmel, James Signorovitch, Gautam Sajeev, Jorge A Quiroz, Jonathan S. Varsanik, Genevieve A. Laforet, Valeria Ricotti
Publikováno v:
Journal of Medical Engineering & Technology. 43:182-189
Ambient measurement systems (AMSs) can enable continuous assessment of functional performance at home, increasing the availability of data for monitoring of neuromuscular disease. An AMS passively measures movement whenever someone is in range of the
Autor:
Tuula Tyry, Amber Salter, Denise Campagnolo, Genevieve A. Laforet, Robert J. Fox, Xiaojun You, Jennifer Sun
Publikováno v:
International Journal of MS Care. 15:194-201
Injectable first-line disease-modifying therapies (DMTs) for multiple sclerosis (MS) are generally prescribed for continuous use. Accordingly, the various factors that influence patient persistence with treatment and that can lead some patients to sw
Publikováno v:
Alzheimer Disease & Associated Disorders. 25:73-84
Model-based statistical approaches were used to compare the ability of the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog), cerebrospinal fluid (CSF), fluorodeoxyglu- cose positron emission tomography and volumetric magnetic resona
Autor:
Mario D. Saltarelli, Walid M. Abi-Saab, Genevieve A. Laforet, Donald W. Lewis, Julie M. Fugate, George Apostol, Weining Z. Robieson
Publikováno v:
Headache: The Journal of Head and Face Pain. 49:45-53
Objective.— The objective of this long-term open-label study in adolescents was to assess the safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches. Background.— Two formulations of divalproex sodi
Autor:
Evelyn Olson, George Apostol, Weining Z. Robieson, Genevieve A. Laforet, Walid M. Abi-Saab, Roger Cady, Mario D. Saltarelli
Publikováno v:
Headache: The Journal of Head and Face Pain. 48:1012-1025
Objective.— To evaluate the efficacy, tolerability, and safety of 3 different doses of divalproex sodium extended-release vs placebo in the prophylaxis of migraine headaches in adolescents. Background.— Divalproex sodium has been approved for mig
Background: The main clinical determinants of quality of life (QOL) 5 years after clinically isolated syndrome (CIS) are Expanded Disability Status Scale (EDSS) score and conversion to clinically definite multiple sclerosis (CDMS). The aim of this st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8e15563ec0ee64df6cff963568aa07e
https://europepmc.org/articles/PMC4338640/
https://europepmc.org/articles/PMC4338640/
Autor:
E S Jokel, Kathryn Chase, Carlos Cepeda, Frederick M. Boyce, B A Cadigan, L Warzecki, Michael Levine, C McIntyre, Neil Aronin, Gloria J. Klapstein, M Campbell, Genevieve A. Laforet, P. H. Reddy, C R Calvert, Marian DiFiglia, D A Tagle, M. A. Ariano, E Sapp
Publikováno v:
The Journal of Neuroscience. 21:9112-9123
Neurons in Huntington's disease exhibit selective morphological and subcellular alterations in the striatum and cortex. The link between these neuronal changes and behavioral abnormalities is unclear. We investigated relationships between essential n
Publikováno v:
Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences. 354:995-1003
Studies of huntingtin localization in human post–mortem brain offer insights and a framework for basic experiments in the pathogenesis of Huntington'sdisease. In neurons of cortex and striatum, we identified changes in the cytoplasmic localization
Publikováno v:
Multiple sclerosis and related disorders. 2(4)
Background: Criteria for identifying relapsing multiple sclerosis (RMS) patients with aggressive disease, which would be useful for clinical decision making, are currently unavailable. Objective: Identify RMS patients with aggressive disease characte
Publikováno v:
Alzheimer's & Dementia. 6